{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T09:25:46Z","timestamp":1789809946636,"version":"4.0.1"},"reference-count":45,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Technology Commission","award":["201440595"],"award-info":[{"award-number":["201440595"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pathology - Research and Practice"],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.1016\/j.prp.2018.01.001","type":"journal-article","created":{"date-parts":[[2018,1,9]],"date-time":"2018-01-09T03:05:32Z","timestamp":1515467132000},"page":"374-379","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":36,"title":["MiR-21-5p, miR-34a, and human telomerase RNA component as surrogate markers for cervical cancer progression"],"prefix":"10.1016","volume":"214","author":[{"given":"Yue","family":"Zhu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tian","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peihong","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guan","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yungui","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.prp.2018.01.001_bib0005","series-title":"GLOBOCAN 2012. Cancer Incidence and Mortality Worldwide: IARC Cancer Base No. 11 [Internet]","author":"Ferlay","year":"2016"},{"issue":"2","key":"10.1016\/j.prp.2018.01.001_bib0010","doi-asserted-by":"crossref","first-page":"87","DOI":"10.3322\/caac.21262","article-title":"Global cancer statistics: 2012","volume":"65","author":"Torre","year":"2015","journal-title":"CA. Cancer J. Clin."},{"issue":"4","key":"10.1016\/j.prp.2018.01.001_bib0015","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1097\/LGT.0b013e3181585870","article-title":"2006 consensus guidelines for the management of women with abnormal cervical screening tests","volume":"11","author":"Wright","year":"2007","journal-title":"J. Low. Genit. Tract Dis."},{"issue":"10","key":"10.1016\/j.prp.2018.01.001_bib0020","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1016\/S1470-2045(16)30275-3","article-title":"Preventable fractions of cervical cancer via effective screening in six Baltic, central, and eastern European countries 2017-40: a population-based study","volume":"17","author":"Vaccarella","year":"2016","journal-title":"Lancet Oncol."},{"issue":"9916","key":"10.1016\/j.prp.2018.01.001_bib0025","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/S0140-6736(13)62218-7","article-title":"Efficacy of HPV-based screening for prevention of invasive cervical cancer: follow-up of four European randomised controlled trials","volume":"383","author":"Ronco","year":"2014","journal-title":"The Lancet"},{"issue":"7","key":"10.1016\/j.prp.2018.01.001_bib0030","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1158\/1055-9965.EPI-07-2922","article-title":"A systematic review of the prevalence and attribution of human papillomavirus types among cervical: vaginal, and vulvar precancers and cancers in the United States","volume":"17","author":"Insinga","year":"2008","journal-title":"Cancer Epidemiol. Prevention Biomark."},{"issue":"2","key":"10.1016\/j.prp.2018.01.001_bib0035","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0092-8674(04)00045-5","article-title":"MicroRNAs: genomics, biogenesis, mechanism, and function","volume":"116","author":"Bartel","year":"2004","journal-title":"Cell"},{"issue":"3","key":"10.1016\/j.prp.2018.01.001_bib0040","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.cell.2012.04.005","article-title":"Roles for microRNAs in conferring robustness to biological processes","volume":"149","author":"Ebert","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.prp.2018.01.001_bib0045","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1146\/annurev.med.59.053006.104707","article-title":"MicroRNAs in cancer","volume":"60","author":"Garzon","year":"2009","journal-title":"Annu. Rev. Med."},{"issue":"3","key":"10.1016\/j.prp.2018.01.001_bib0050","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1002\/emmm.201100209","article-title":"MicroRNA dysregulation in cancer: diagnostics, monitoring and therapeutics. A comprehensive review","volume":"4","author":"Iorio","year":"2012","journal-title":"EMBO Mol. Med."},{"issue":"8","key":"10.1016\/j.prp.2018.01.001_bib0055","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.molmed.2014.06.005","article-title":"MicroRNAs in cancer: biomarkers, functions and therapy","volume":"20","author":"Hayes","year":"2014","journal-title":"Trends Mol. Med."},{"issue":"1","key":"10.1016\/j.prp.2018.01.001_bib0060","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1756-8722-7-6","article-title":"Differentially expressed microRNAs in the serum of cervical squamous cell carcinoma patients before and after surgery","volume":"7","author":"Wang","year":"2014","journal-title":"J. Hematol. Oncol."},{"issue":"2","key":"10.1016\/j.prp.2018.01.001_bib0065","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.bbadis.2011.09.018","article-title":"MiR-21 is involved in cervical squamous cell tumorigenesis and regulates CCL20","volume":"1822","author":"Yao","year":"2012","journal-title":"Biochimica et Biophysica Acta (BBA)-Mol. Basis Dis."},{"issue":"3","key":"10.1016\/j.prp.2018.01.001_bib0070","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.bbrc.2009.08.044","article-title":"MicroRNA-21 promotes cell proliferation and down-regulates the expression of programmed cell death 4 (PDCD4) in HeLa cervical carcinoma cells","volume":"388","author":"Yao","year":"2009","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"1","key":"10.1016\/j.prp.2018.01.001_bib0075","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1186\/1471-2407-14-996","article-title":"Deregulation of microRNAs Let-7a and miR-21 mediate aberrant STAT3 signaling during human papillomavirus-induced cervical carcinogenesis: role of E6 oncoprotein","volume":"14","author":"Shishodia","year":"2014","journal-title":"BMC Cancer"},{"issue":"4","key":"10.1016\/j.prp.2018.01.001_bib0080","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/j.bbrc.2015.03.004","article-title":"miR-21 modulates resistance of HR-HPV positive cervical cancer cells to radiation through targeting LATS1","volume":"459","author":"Liu","year":"2015","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"4","key":"10.1016\/j.prp.2018.01.001_bib0085","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1261\/rna.1442309","article-title":"Oncogenic HPV infection interrupts the expression of tumor-suppressive miR-34a through viral oncoprotein E6","volume":"15","author":"Wang","year":"2009","journal-title":"RNA"},{"issue":"4","key":"10.1016\/j.prp.2018.01.001_bib0090","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1111\/IGC.0b013e3181d63170","article-title":"Reduced miR-34a expression in normal cervical tissues and cervical lesions with high-risk human papillomavirus infection","volume":"20","author":"Li","year":"2010","journal-title":"Int. J. Gynecol. Cancer"},{"issue":"9","key":"10.1016\/j.prp.2018.01.001_bib0095","doi-asserted-by":"crossref","first-page":"dju241","DOI":"10.1093\/jnci\/dju241","article-title":"MicrorNA Detection in cervical exfoliated cells as a triage for Human Papillomavirus-Positive Women","volume":"106","author":"Tian","year":"2014","journal-title":"J. Natl. Cancer Inst."},{"issue":"13","key":"10.1016\/j.prp.2018.01.001_bib0100","doi-asserted-by":"crossref","first-page":"2626","DOI":"10.1200\/JCO.2000.18.13.2626","article-title":"Role of telomerase in normal and cancer cells","volume":"18","author":"Meyerson","year":"2000","journal-title":"J. Clin. Oncol."},{"issue":"5","key":"10.1016\/j.prp.2018.01.001_bib0105","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.2353\/ajpath.2009.090122","article-title":"Detection of genomic amplification of the human telomerase gene TERC: a potential marker for triage of women with HPV-positive, abnormal Pap smears","volume":"175","author":"Andersson","year":"2009","journal-title":"Am. J. Pathol."},{"issue":"4","key":"10.1016\/j.prp.2018.01.001_bib0110","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1016\/S0002-9440(10)62341-3","article-title":"Genomic amplification of the human telomerase gene (TERC) in pap smears predicts the development of cervical cancer","volume":"166","author":"Heselmeyer-Haddad","year":"2005","journal-title":"Am. J. Pathol."},{"issue":"4","key":"10.1016\/j.prp.2018.01.001_bib0115","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1016\/S0002-9440(10)63498-0","article-title":"Detection of genomic amplification of the human telomerase gene (TERC) in cytologic specimens as a genetic test for the diagnosis of cervical dysplasia","volume":"163","author":"Heselmeyer-Haddad","year":"2003","journal-title":"Am. J. Pathol."},{"issue":"8","key":"10.1016\/j.prp.2018.01.001_bib0120","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1097\/PAS.0b013e3181e8b2c4","article-title":"Using biomarkers as objective standards in the diagnosis of cervical biopsies","volume":"34","author":"Galgano","year":"2010","journal-title":"Am. J. Surgical Pathol."},{"issue":"16","key":"10.1016\/j.prp.2018.01.001_bib0125","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1001\/jama.287.16.2114","article-title":"The 2001 Bethesda System: terminology for reporting results of cervical cytology","volume":"287","author":"Solomon","year":"2002","journal-title":"JAMA"},{"issue":"6","key":"10.1016\/j.prp.2018.01.001_bib0130","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1038\/nprot.2008.73","article-title":"Analyzing real-time PCR data by the comparative CT method","volume":"3","author":"Schmittgen","year":"2008","journal-title":"Nat. Protoc."},{"issue":"1","key":"10.1016\/j.prp.2018.01.001_bib0135","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.ajpath.2012.08.042","article-title":"Long intergenic noncoding RNA HOTAIR is overexpressed and regulates PTEN methylation in laryngeal squamous cell carcinoma","volume":"182","author":"Li","year":"2013","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.prp.2018.01.001_bib0140","series-title":"Clinical Gynecologic Oncology","author":"DiSaia","year":"2012"},{"issue":"3","key":"10.1016\/j.prp.2018.01.001_bib0145","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1093\/jnci\/91.3.252","article-title":"Natural history of dysplasia of the uterine cervix","volume":"91","author":"Holowaty","year":"1999","journal-title":"J. Natl. Cancer Inst."},{"issue":"3\u20134","key":"10.1016\/j.prp.2018.01.001_bib0150","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1007\/s10555-009-9188-5","article-title":"MicroRNA function in cancer: oncogene or a tumor suppressor?","volume":"28","author":"Shenouda","year":"2009","journal-title":"Cancer Metastasis Rev."},{"issue":"7","key":"10.1016\/j.prp.2018.01.001_bib0155","doi-asserted-by":"crossref","first-page":"e2557","DOI":"10.1371\/journal.pone.0002557","article-title":"Aberrant expression of oncogenic and tumor-suppressive microRNAs in cervical cancer is required for cancer cell growth","volume":"3","author":"Wang","year":"2008","journal-title":"PLoS One"},{"issue":"13","key":"10.1016\/j.prp.2018.01.001_bib0160","doi-asserted-by":"crossref","first-page":"6031","DOI":"10.1158\/0008-5472.CAN-06-0561","article-title":"Patterns of known and novel small RNAs in human cervical cancer","volume":"67","author":"Lui","year":"2007","journal-title":"Cancer Res."},{"issue":"6","key":"10.1016\/j.prp.2018.01.001_bib0165","first-page":"7131","article-title":"Dysregulation of miRNA-21 and their potential as biomarkers for the diagnosis of cervical cancer","volume":"8","author":"Han","year":"2015","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"10.1016\/j.prp.2018.01.001_bib0170","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1146\/annurev-pathol-012513-104715","article-title":"MicroRNAs in cancer","volume":"9","author":"Di Leva","year":"2014","journal-title":"Annu. Rev. Pathol.: Mech. Dis."},{"issue":"1","key":"10.1016\/j.prp.2018.01.001_bib0175","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1002\/(SICI)1096-9896(199909)189:1<12::AID-PATH431>3.0.CO;2-F","article-title":"Human papillomavirus is a necessary cause of invasive cervical cancer worldwide","volume":"189","author":"Walboomers","year":"1999","journal-title":"J. Pathol."},{"issue":"4","key":"10.1016\/j.prp.2018.01.001_bib0180","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1002\/(SICI)1098-2264(199708)19:4<233::AID-GCC5>3.0.CO;2-Y","article-title":"Advanced-stage cervical carcinomas are defined by a recurrent pattern of chromosomal aberrations revealing high genetic instability and a consistent gain of chromosome arm 3q","volume":"19","author":"Heselmeyer","year":"1997","journal-title":"Genes Chromosomes Cancer"},{"issue":"1","key":"10.1016\/j.prp.2018.01.001_bib0185","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.ygyno.2010.10.007","article-title":"Application of hTERC in thinprep samples with mild cytologic abnormality and HR-HPV positive","volume":"120","author":"Li","year":"2011","journal-title":"Gynecol. Oncol."},{"issue":"4","key":"10.1016\/j.prp.2018.01.001_bib0190","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1111\/IGC.0b013e3181c50c7e","article-title":"Detection of human telomerase RNA gene in cervical cancer and precancerous lesions: comparison with cytological and human papillomavirus DNA test findings","volume":"20","author":"Li","year":"2010","journal-title":"Int. J. Gynecol. Cancer"},{"issue":"4","key":"10.1016\/j.prp.2018.01.001_bib0195","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1002\/path.2070","article-title":"Genomic integration of oncogenic HPV and gain of the human telomerase gene TERC at 3q26 are strongly associated events in the progression of uterine cervical dysplasia to invasive cancer","volume":"210","author":"Hopman","year":"2006","journal-title":"J. Pathol."},{"issue":"1","key":"10.1016\/j.prp.2018.01.001_bib0200","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.ygyno.2008.01.040","article-title":"Gain of the 3q26 region in cervicovaginal liquid-based pap preparations is associated with squamous intraepithelial lesions and squamous cell carcinoma","volume":"110","author":"Caraway","year":"2008","journal-title":"Gynecol. Oncol."},{"issue":"3","key":"10.1016\/j.prp.2018.01.001_bib0205","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1038\/sj.bjc.6603253","article-title":"Frequent gain of the human telomerase gene TERC at 3q26 in cervical adenocarcinomas","volume":"95","author":"Andersson","year":"2006","journal-title":"Br. J. Cancer"},{"issue":"1","key":"10.1016\/j.prp.2018.01.001_bib0210","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.cancergencyto.2009.01.004","article-title":"Genomic amplification of the human telomerase RNA gene for differential diagnosis of cervical disorders","volume":"191","author":"Tu","year":"2009","journal-title":"Cancer Genet. Cytogenet."},{"issue":"4","key":"10.1016\/j.prp.2018.01.001_bib0215","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1002\/ijc.23210","article-title":"Gene expression profiling to identify markers associated with deregulated hTERT in HPV-transformed keratinocytes and cervical cancer","volume":"122","author":"de Wilde","year":"2008","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.prp.2018.01.001_bib0220","first-page":"1167","article-title":"Clinical significance of human telomerase RNA gene (hTERC) amplification in cervical squamous cell lesions detected by fluorescence in situ hybridization","volume":"12","author":"Guo","year":"2011","journal-title":"Asian Pac. J. Cancer Prev."},{"issue":"10","key":"10.1016\/j.prp.2018.01.001_bib0225","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1002\/dc.21635","article-title":"Different amplification patterns of the human telomerase RNA gene in invasive cervical carcinomas and cervical intraepithelial neoplasia grade III","volume":"40","author":"Xiang","year":"2012","journal-title":"Diagn. Cytopathol."}],"container-title":["Pathology - Research and Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033817310130?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033817310130?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,24]],"date-time":"2018-08-24T16:51:55Z","timestamp":1535129515000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0344033817310130"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3]]},"references-count":45,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,3]]}},"alternative-id":["S0344033817310130"],"URL":"https:\/\/doi.org\/10.1016\/j.prp.2018.01.001","relation":{},"ISSN":["0344-0338"],"issn-type":[{"value":"0344-0338","type":"print"}],"subject":[],"published":{"date-parts":[[2018,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"MiR-21-5p, miR-34a, and human telomerase RNA component as surrogate markers for cervical cancer progression","name":"articletitle","label":"Article Title"},{"value":"Pathology - Research and Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.prp.2018.01.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier GmbH. All rights reserved.","name":"copyright","label":"Copyright"}]}}